Ultraviolet B induced suppression of induction of contact sensitivity in human skin is not associated with tumour necrosis factor-alpha-308 or interleukin-10 genetic polymorphisms. 1998

M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
St John's Institute of Dermatology, St Thomas' Hospital, London, SE1 7EH, U.K.

Low doses of ultraviolet B (UVB) can induce localized immunosuppression in skin. This effect may be important in the induction of skin cancers and is thought to be mediated by tumour necrosis factor (TNF) alpha and interleukin (IL) 10 in conjunction with other factors. In humans a transition polymorphism in the TNF-alpha gene may affect TNF-alpha secretion and the promoter region of the IL-10 gene contains a CA repeat polymorphism which may affect gene function. We have therefore investigated the association of these polymorphisms with UVB-induced immunosuppression in humans. Volunteers (n = 42) were irradiated with UVB then sensitized on irradiated skin with diphenylcyclopropanone (DPCP) and subsequently antigen challenged with DPCP. DNA was extracted from blood samples and volunteers genotyped for the TNF-alpha polymorphism by polymerase chain reaction (PCR) and restriction digestion. The CA repeat polymorphism was amplified by PCR and sized by gel electrophoresis. Twenty-four volunteers were susceptible to UVB-induced immunosuppression and 18 were resistant. The association of allele frequencies and phenotype was statistically tested using a chi2-test. For both the TNF-alpha and IL-10 polymorphisms, there was no statistically significant association between allele types and response to UVB. These results indicate that variation in the immune response to UVB in humans is not associated with the TNF-alpha-308 transition or IL-10 CA repeat polymorphisms, although other as yet undetected DNA sequence variants of these genes may be involved.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D008297 Male Males
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D003877 Dermatitis, Contact A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms. Contact Dermatitis,Dermatitis Venenata,Eczema, Contact,Hypersensitivity, Contact,Sensitivity, Contact,Contact Dermatitides,Contact Eczema,Contact Hypersensitivities,Contact Hypersensitivity,Contact Sensitivities,Contact Sensitivity,Dermatitides, Contact,Hypersensitivities, Contact,Sensitivities, Contact
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
November 2001, Clinical and experimental dermatology,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
January 1994, Immunology,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
October 2005, European journal of gastroenterology & hepatology,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
April 2001, European journal of pharmacology,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
August 2001, Gut,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
August 1994, The American journal of the medical sciences,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
May 2010, European journal of obstetrics, gynecology, and reproductive biology,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
January 2008, Allergy and asthma proceedings,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
June 1992, Immunology,
M H Allen, and L Skov, and R Barber, and R Trembath, and J Simon, and O Baadsgaard, and J N Barker
June 2000, The British journal of dermatology,
Copied contents to your clipboard!